1. Home
  2. CDT

as of 05-19-2026 12:30pm EST

$1.21
$0.29
-19.67%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. The company has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The group is committed to creating shareholder value through licensing, strategic M&A, and positioning the company as a platform for transformative innovation.

Founded: 2019 Country:
United States
United States
Employees: 6 City: NAPLES
Market Cap: 22.1M IPO Year: N/A
Target Price: N/A AVG Volume (30 days): 32.9K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $0.37 - $11.00 Next Earning Date: 04-15-2026
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

AI-Powered CDT Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 17 hours ago

AI Recommendation

hold
Model Accuracy: 75.64%
75.64%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: